NCT03177395View on ClinicalTrials.gov

PP100-01 (Calmangafodipir) for Overdose of Paracetamol

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

August 8, 2018

Study Completion Date

November 8, 2018

Conditions
Paracetamol Overdose
Interventions
DRUG

PP100-01 (calmangafodipir)

PP100-01

DRUG

Acetylcysteine

NAC

Trial Locations (1)

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

Sponsors
All Listed Sponsors
collaborator

University of Edinburgh

OTHER

collaborator

NHS Lothian

OTHER_GOV

lead

Egetis Therapeutics

INDUSTRY

NCT03177395 - PP100-01 (Calmangafodipir) for Overdose of Paracetamol | Biotech Hunter | Biotech Hunter